Pompe Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
SKU : PH1484
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Pompe Disease Therapeutics Market ?
The global Pompe disease therapeutics market reached USD 1.3 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 1.9 billion by 2031.
Who are the key players in Pompe Disease Therapeutics Market ?
Major players are Genzyme (Sanofi), Amicus Therapeutics, Valerion Therapeutics, Audentes Therapeutics, Actus Therapeutics, BioMarin Pharmaceutical, EpiVax, Oxyrane, Sangamo BioSciences, Avrobio and Spark Therapeutics.
Related Reports
pharmaceuticals

Acute Intermittent Porphyria Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 October 06
Starting from

$4350

pharmaceuticals

Dependent Insulinotropic Receptor Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01
Starting from

$4350

pharmaceuticals

Metabolic Disorders Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Rare Haematology Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 04
Starting from

$4350

pharmaceuticals

Gaucher Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Parkinson’s disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350